Structure–activity relationship of a series of non peptidic RGD integrin antagonists targeting α5β1: Part 2
✍ Scribed by Bénédicte Delouvrié; Katherine Al-Kadhimi; Jean-Claude Arnould; Simon T. Barry; Darren A.E. Cross; Myriam Didelot; Paul R. Gavine; Hervé Germain; Craig S. Harris; Adina M. Hughes; David A. Jude; Jane Kendrew; Christine Lambert-van der Brempt; Jean-Jacques Lohmann; Morgan Ménard; Andrew A. Mortlock; Martin Pass; Claire Rooney; Michel Vautier; Jennifer L. Vincent; Nicolas Warin
- Book ID
- 113496883
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 830 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract α~4~β~1~ integrin is a therapeutic target for inflammation, autoimmune diseases, and lymphoid cancers. A series of peptidomimetic ligands based on the Nle‐D‐I motif have been synthesized and their binding affinities (IC~50~) to activated α~4~β~1~ integrin on Jurkat T‐leukemia cells have